4th International Congress on Prediabetes and the Metabolic Syndrome 2011

Prediabetes and the Metabolic Syndrome are highly prevalent conditions, affecting between one in six and one in three adults in most developed countries, and a similar proportion in the urban areas of many developing countries. Both conditions have a big public health importance because they are associated with a markedly increased risk of diabetes and cardiovascular disease (CVD), thus contributing to the epidemic proportions of these diseases.

Major clinical trials performed in recent years have shown that diabetes can be prevented in people with prediabetes by intensive lifestyle changes, and also by the use of several drugs. Serious drives to prevent diabetes were started in several countries around the world aiming first at the high-risk population, people with prediabetes. This situation has led us to initiate the series of International Congresses on Prediabetes and the Metabolic Syndrome. The first three congresses, in Berlin (2005), in Barcelona (2007), and in Nice (2009) were very successful, and established a meeting place for clinicians from several disciplines and basic scientists, all interested in prevention of diabetes and CVD.

Diabetes is an important CVD risk factor, and impaired glucose metabolism among cardiac patients is extremely prevalent. We aim to deepen and intensify the cardio-diabetes alliance in treatment and prevention. We hope that cardiologists will find the program attractive, and choose to participate in the congress.

Pharmaceutical companies are very active in testing new drugs, affecting Diabetes, and possible pathophysiological mechanisms of the Metabolic Syndrome. The congress will provide a platform for presentation of basic and clinical trial research results on novel therapies.

Main Topics:

Epidemiology of Prediabetes and the Metabolic Syndrome

Genetics and environment in children and adults

Insulin resistance and atherosclerosis

Vascular biology and CVD risk of the Metabolic Syndrome

Impact of nutrition and exercise

New screening methods for the people at risk

Pharmacological prevention and treatment of Diabetes

Pharmacological prevention of the Metabolic Syndrome and CVD

Socio-economic aspects and politics of the Metabolic Syndrome